CIK: 1589259 - Address: C/o Medicinova, Inc., 4275 Executive Square, Suite 300, La Jolla, CA 92037
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret117451017181311
P%wins8610086100718087

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

5/16/17 14:52
5/15/17
MNOVMedicinova IncDEHealthDrugPharmaceutical PreparationsKobayashi YutakaCADP65.60011107I41-18-23-10-91-31
5/15/17 18:27
5/12/17
MNOVMedicinova IncDEHealthDrugPharmaceutical PreparationsKobayashi YutakaCADP1355.6202429106I41-18-23-10-91-31
9/15/16 14:10
9/15/16
MNOVMedicinova IncDEHealthDrugPharmaceutical PreparationsKobayashi YutakaCADP766.440121782D100113121351240136-11
9/9/16 18:29
9/9/16
MNOVMedicinova IncDEHealthDrugPharmaceutical PreparationsKobayashi YutakaCADP676.670101770D16411218-28-48963917-7
12/10/14 16:57
12/10/14
MNOVMedicinova IncDEHealthDrugPharmaceutical PreparationsKobayashi YutakaCADP423.540122560D97607821-112316920-4122-1
11/28/14 17:00
11/26/14
MNOVMedicinova IncDEHealthDrugPharmaceutical PreparationsKobayashi YutakaCADP313.070102648D70435939-33-2531962162914
11/21/14 17:34
11/20/14
MNOVMedicinova IncDEHealthDrugPharmaceutical PreparationsKobayashi YutakaCADP413.190135238D78357751-18-13-33-30316309
9/11/14 17:44
9/11/14
MNOVMedicinova IncDEHealthDrugPharmaceutical PreparationsKobayashi YutakaCADP302.950106725D54253247464024263128211510
9/4/14 18:50
9/3/14
MNOVMedicinova IncDEHealthDrugPharmaceutical PreparationsKobayashi YutakaCADP402.66015New15D37915262820221102430445032

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact